Celularity (CELUW) Invested Capital (2018 - 2025)
Celularity (CELUW) reported Invested Capital of -$38.0 million for Q4 2025, down 184.82% year-over-year from $44.8 million in Q4 2024, and down 140.16% quarter-over-quarter from -$15.8 million in Q3 2025.
Celularity (CELUW) Invested Capital (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Invested Capital data on file, last reported at -$38.0 million in Q4 2025.
- Invested Capital for Q4 2025 came in at -$38.0 million, down 184.82% year-over-year; the trailing twelve-month figure through Dec 2025 was -$38.0 million (down 184.82% YoY), and the FY2025 annual result was -$38.0 million, down 184.82% from the prior year.
- Invested Capital fell to -$38.0 million in Q4 2025 per CELUW's latest filing, from -$15.8 million in the prior quarter.
- Over five years, Invested Capital peaked at $236.5 million in Q4 2022 and troughed at -$648.2 million in Q2 2021.
- A 5-year average of $2.9 million and a median of $44.5 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2022 and 2025: Invested Capital surged 137.89% in 2022, then slumped 191.49% in 2025.
- A 5-year view of Invested Capital shows it stood at $99.4 million in 2021, then jumped by 137.89% to $236.5 million in 2022, then plunged by 75.4% to $58.2 million in 2023, then dropped by 23.06% to $44.8 million in 2024, then sank by 184.82% to -$38.0 million in 2025.
- Business Quant data shows CELUW's Invested Capital at -$38.0 million in Q4 2025, -$15.8 million in Q3 2025, and -$21.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -37.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -37.97 Mn |
| Sep 30, 2025 | -15.81 Mn |
| Jun 30, 2025 | -21.20 Mn |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | 44.76 Mn |
| Sep 30, 2024 | 17.28 Mn |
| Jun 30, 2024 | 27.81 Mn |
| Mar 31, 2024 | 31.25 Mn |
| Dec 31, 2023 | 58.18 Mn |
| Sep 30, 2023 | 44.25 Mn |
| Jun 30, 2023 | 135.53 Mn |
| Mar 31, 2023 | 160.37 Mn |
| Dec 31, 2022 | 236.50 Mn |
| Sep 30, 2022 | 203.49 Mn |
| Jun 30, 2022 | 150.15 Mn |
| Mar 31, 2022 | 89.91 Mn |
| Dec 31, 2021 | 99.42 Mn |
| Sep 30, 2021 | 96.22 Mn |
| Jun 30, 2021 | -648.21 Mn |
| Mar 31, 2021 | -611.93 Mn |